NCT06502743: First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 92 planned
- Started
- 12 Sep 2024
- Primary completion
- 27 Dec 2027
- Arms
- Part B - Pembrolizumab and nesuparib combination therapy, Part A - Safety Run-in Phase
- Results
- None posted
- 16 Jul 2024: Trial registered
- 12 Sep 2024: Trial started